No Picture
News

Biological Dynamics Expands Biomarkers Research Into Alzheimer’s With Funding From Alzheimer’s Drug Discovery Foundation (ADDF)

The novel Verita(TM) diagnostics platform will power a portfolio of novel blood-based biomarkers for drug development tools

SAN DIEGO, July 29, 2020 /PRNewswire/ — Biological Dynamics, Inc., an innovative diagnostic company committed to improving gl… […]

No Picture
News

MVPvets Appoints New Board Member and Launches The Academy, Providing Veterans with Virtual Training, Mentorship, and Access to The MedTech Conference

SAN DIEGO, July 28, 2020 /PRNewswire/ — MVPvets, a 501(c)(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in medical device and life science companies, announced the appointment of board… […]

No Picture
News

Phanes Therapeutics reveals a new bispecific antibody technology platform at BIO Digital 2020

SAN DIEGO, June 16, 2020 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has developed a proprietary bispecific antibody technology platform, PACbodyT… […]

No Picture
News

Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville, Plans to Develop AS1411 for the Treatment of COVID-19

CARLSBAD, Calif., June 10, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today the signing of an exclusive license agreement with the University of Louisville (UofL) to facilitate developme… […]

No Picture
News

Nucleus Biologics Unveils World’s First Online Portal for Instantaneous Custom cGMP Cell Culture Media Configuration

SAN DIEGO, May 27, 2020 /PRNewswire/ — Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™, an online configuration and ordering platform for cell culture media. Designed for developers of cell therapi… […]

No Picture
News

Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector(TM) BRAF Kit for Clients’ Use in Their Own Laboratories

Target Selector(TM) molecular assay kits are research-use-only (RUO) and offer superior sensitivity compared to NGS-based biomarker analysis for the detection of key actionable oncogene mutations

SAN DIEGO, May 14, 2020 /PRNewswire/ — Biocept, Inc. … […]

No Picture
News

Roswell Biotechnologies and Imec to Develop First Molecular Electronics Biosensor Chips for Infectious Disease Surveillance, Precision Medicine and DNA Storage

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices

SAN DIEGO and LEUVEN, Belgium, May 5, 2020 /PRNewswire/ — Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading researc… […]

No Picture
News

Roswell Biotechnologies and Imec to Develop First Molecular Electronics Biosensor Chips for Infectious Disease Surveillance, Precision Medicine and DNA Storage

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices

SAN DIEGO and LEUVEN, Belgium, May 5, 2020 /PRNewswire/ — Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading researc… […]

No Picture
News

Brazil Patent Granted for Biocept’s Target Selector(TM) Oncogene Mutation Enrichment and Detection Platform

Expands global intellectual property portfolio for highly sensitive methods of detecting cancer biomarkers in circulating tumor DNA (ctDNA) and other genetic alterations of interest; increases Biocept’s total patent awards for technologies used in mole… […]

No Picture
News

Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market

BEIJING and?SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen,?a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]

No Picture
News

Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market

BEIJING and?SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ — Shenogen,?a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in China … […]

No Picture
News

Persephone Biosciences Announces AI-Driven Microbiome Therapeutic and Diagnostic Programs for COVID-19

Treatment approach goes beyond combating COVID-19 and may be effective against mutations, seasonal flu and future pandemics

SAN DIEGO, April 2, 2020 /PRNewswire/ — Persephone Biosciences Inc., a biotechnology company that designs microbiome therape… […]

No Picture
News

Primmune Therapeutics Announces the Selection of PRTX007 as Its Clinical Development Candidate for COVID-19 and Oncology Indications

SAN DIEGO, March 31, 2020 /PRNewswire/ –?Primmune Therapeutics announced today that it has selected PRTX007 as its lead clinical development candidate for SARS-CoV-2 (the virus that causes COVID-19) and for oncology indications.

“PRTX007 is … […]

No Picture
News

Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections

-Forge is eligible to receive $190.5M in total payments-

SAN DIEGO, March 25, 2020 /PRNewswire/ — Forge Therapeutics, Inc. (Forge) announced today that they have entered into a research collaboration and option agreement with Hoffmann-La Roche Ltd. … […]